MedPath

Kafrelsheikh University

Kafrelsheikh University logo
🇪🇬Egypt
Ownership
Private
Employees
-
Market Cap
-
Website
http://kfs.edu.eg

Clinical Trials

214

Active:15
Completed:92

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:7
Phase 2:13
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (193 trials with phase data)• Click on a phase to view related trials

Not Applicable
127 (65.8%)
Phase 3
27 (14.0%)
Phase 4
18 (9.3%)
Phase 2
13 (6.7%)
Phase 1
7 (3.6%)
Early Phase 1
1 (0.5%)

Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction

Not Applicable
Recruiting
Conditions
Sacubitril/Valsartan
Heart Failure
Prosthetic Heart Valve
Reduced Ejection Fraction
Interventions
Drug: Conventional anti-heart failure therapy
First Posted Date
2025-09-25
Last Posted Date
2025-09-30
Lead Sponsor
Kafrelsheikh University
Target Recruit Count
220
Registration Number
NCT07192341
Locations
🇪🇬

Kafrelsheikh University, Kafr ash Shaykh, Kafrelsheikh, Egypt

Foam and Liquid Sclerotherapy With or Without Herbal Gel for Small Vein Treatment

Not Applicable
Active, not recruiting
Conditions
Telangectasia
Reticular Veins
First Posted Date
2025-09-09
Last Posted Date
2025-09-09
Lead Sponsor
Kafrelsheikh University
Target Recruit Count
508
Registration Number
NCT07162844
Locations
🇪🇬

Faculty of medicine kfs university, Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt

Comparative Study of Negative-Pressure Wound Therapy Integrated With Silver Nanoparticle Spray Versus Negative-Pressure Wound Therapy in Post-Revascularization Diabetic Foot Wound Management

Conditions
Ischemia Limb
Diabete Mellitus
Interventions
First Posted Date
2025-08-29
Last Posted Date
2025-09-11
Lead Sponsor
Kafrelsheikh University
Target Recruit Count
100
Registration Number
NCT07147790
Locations
🇪🇬

Kafr El Shaykh University, Kafr ash Shaykh, Kafrelshaykh Governorate, Egypt

Comparison Between Treatments of Oligohydramnios

Not Applicable
Recruiting
Conditions
Oligohydramnios
Interventions
Drug: Sildenafil 25 MG
Drug: L-Arginine, 1000 Mg Oral Tablet
First Posted Date
2025-08-21
Last Posted Date
2025-08-21
Lead Sponsor
Kafrelsheikh University
Target Recruit Count
40
Registration Number
NCT07135037
Locations
🇪🇬

Kafrelsheikh University Hospital, Kafr Ash Shaykh, Kafrelsheikh, Egypt

🇪🇬

Kafrelsheokh university hospital, Kafr Ash Shaykh, Kafrelsheikh, Egypt

L-PRF vs Connective Tissue With Customized Healing Abutment in Immediate Implant Placement

Not Applicable
Recruiting
Conditions
Recession, Gingival
Bone Loss in Jaw
First Posted Date
2025-08-05
Last Posted Date
2025-08-14
Lead Sponsor
Kafrelsheikh University
Target Recruit Count
16
Registration Number
NCT07102758
Locations
🇪🇬

Kafrelsheikh University, Kafr Ash Shaykh, Kafrelsheikh, Egypt

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 43
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.